Dexamethasone, a cheap and widely used steroid used to reduce inflammation for patients afflicted with arthritis, asthma, some skin conditions, and more, has been recognized as a breakthrough treatment from severely ill COVID-19 patients. When in use, it has shown to decrease the risk of death by a third for patients on ventilators, and for those on oxygen decrease it by a fifth. Chris Whitty, England’s chief medical officer, has described the announcement on Tuesday (6/16) as “the most important trial result for COVID-19 so far.” 

Read more here

More on: